Inventiva (IVA) Cash from Investing Activities (2019 - 2025)

Inventiva's (IVA) quarterly Cash from Investing Activities came in at -$28.1 million in Q2 2025, down 10166.56% quarter-over-quarter from -$273426.3 in Q4 2022.

Inventiva (IVA) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Inventiva's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$28.1 million for Q2 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$28.1 million in Q2 2025; TTM through Jun 2025 was -$23.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$155.1 million, down 1759.21% from the prior year.
  • Cash from Investing Activities slipped to -$28.1 million in Q2 2025 per IVA's latest filing, from -$273426.3 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $7.7 million in Q1 2021 and bottomed at -$28.1 million in Q2 2025.
  • The 3-year median for Cash from Investing Activities is -$276534.1 (2022), against an average of -$2.9 million.
  • Across the five-year window, Cash from Investing Activities surged 553.88% in 2021 and tumbled 105.04% in 2022, its largest moves.
  • Year by year, Cash from Investing Activities stood at $5.4 million in 2021, then tumbled by 105.04% to -$273426.3 in 2022, then slumped by 10166.56% to -$28.1 million in 2025.
  • Per Business Quant, the three latest IVA Cash from Investing Activities figures stand at -$28.1 million (Q2 2025), -$273426.3 (Q4 2022), and -$279641.8 (Q3 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.57 Bn 466.77 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.01 Bn 114.76 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn -25.54 Mn
10 Inventiva 849.95 Mn 849.95 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.07 Mn
Jun 30, 2025 -28.07 Mn
Dec 31, 2022 -273,426.29
Dec 31, 2022 -273,426.29
Sep 22, 2022 -279,641.81
Sep 22, 2022 -279,641.81
Dec 31, 2021 5.42 Mn
Dec 31, 2021 5.42 Mn
Jun 30, 2021 -1.97 Mn
Jun 30, 2021 -1.97 Mn
Mar 31, 2021 7.69 Mn
Mar 31, 2021 7.69 Mn
Dec 31, 2020 -1.19 Mn
Dec 31, 2020 -1.19 Mn
Dec 31, 2019 -928,678.76
Dec 31, 2019 -928,678.76